Eisai Announces Strategic Alliance With BioArctic Neuroscience To Develop Immunotherapy For Alzheimer's Disease
30-Aug-2005 -
Eisai Co., Ltd. and BioArctic Neuroscience Inc. announced that on August 24, they signed a strategic alliance agreement to develop an immunotherapy for Alzheimer's disease. Based on this agreement, Eisai will obtain first right of refusal for drug candidates developed resulting from the ...
Alzheimer's disease
basic research
neurology